Gene · 406994
MIR212: microRNA 212
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MIR212: microRNA 212. Genes, record 406994. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/406994
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants759
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MIR212 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016058 | Cancer Center Support Grant | 2 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 2 | 2025 |
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 2 | 2025 |
| P30ES007048 | Environmental Exposures, Host Factors and Human Disease | 2 | 2025 |
| P60AA009803 | LSUHSC-NO Comprehensive Alcohol-HIV/AIDS Research Center (CARC) | 2 | 2025 |
| ZIAAG000393 | Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging | 2 | 2025 |
| F30CA260977 | T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1 | 1 | 2025 |
| I01BX000319 | Ischemic Kidney Injury and Kidney Repair: Stress Granules | 1 | 2025 |
| I01BX000332 | Posttranscriptional Control of Gut Mucosal Defense and Homeostasis | 1 | 2025 |
| K12HD047349 | Pediatric Critical Care and Trauma Scientist Development Program (PCCTSDP) | 1 | 2025 |
1 to 10 of 759Source NIH's project files
See all 759 nih grantsPapers1,782
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [miR-212 Is Involved in AML Pathogenesis by Regulating WT1 Expression Through Methylation Modification]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42802427 | PubTator, text mining | PubMed |
| The RBP2-BECN1-VEGFA axis orchestrates a self-amplifying circuit to drive malignant progression in gastric carcinoma. | Front Oncol | 2026 | 42769169 | PubTator, text mining | PubMed |
| MicroRNA Signature in Plasma-Derived Extracellular Vesicles in Frontotemporal Dementia. | Genes (Basel) | 2026 | 42650138 | PubTator, text mining | PubMed |
| The Investigation of MicroRNA Expression Levels in Postmortem Nucleus Accumbens of the Individuals with 6-MAM-Confirmed Heroin-Associated Polysubstance İntoxication: A Case Control Study. | Mol Neurobiol | 2026 | 42518030 | PubTator, text mining | PubMed |
| Abnormal B-Cell Exosome Proapoptotic and Antiapoptotic Cargo in Multiple Sclerosis: Potential Implication in Progressive Disease Biology. | Neurol Neuroimmunol Neuroinflamm | 2026 | 42378709 | PubTator, text mining | PubMed |
| Altered microRNA expression profiles in the postmortem prefrontal cortex of individuals with alcohol use disorder: a case-control study. | Eur Arch Psychiatry Clin Neurosci | 2026 | 42053595 | PubTator, text mining | PubMed |
| Crosstalk between KRAS and miRNAs in pancreatic cancer: Opportunities for its diagnosis, prognosis and therapeutic intervention (Review). | Int J Oncol | 2026 | 41860028 | PubTator, text mining | PubMed |
| The Dual Role of Extracellular Vesicles in Aging and Age-Related Diseases: Pathophysiology and Therapeutic Potential. | Int J Nanomedicine | 2026 | 41810000 | PubTator, text mining | PubMed |
| The dual roles of exosomes in prostate cancer: mechanisms in tumorigenesis and avenues for clinical translation. | Front Immunol | 2026 | 41756279 | PubTator, text mining | PubMed |
| Addictive drug abuse and depression-a focus on epigenetics. | Commun Biol | 2026 | 41723293 | PubTator, text mining | PubMed |
1 to 10 of 1,782
See all 1,782 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/406994
GET https://conductscience.org/api/genes/v1/406994/grants?page=2